Beam Therapeutics INC. (BEAM) — SC 13G/A Filings

All SC 13G/A filings from Beam Therapeutics INC.. Browse 12 SC 13G/A reports with AI-powered summaries and risk analysis.

SC 13G/A Filings (12)

SC 13G/A Filing — Nov 12, 2024
SC 13G/A Filing — Nov 8, 2024
SC 13G/A Filing — Nov 7, 2024
SC 13G/A Filing — Oct 21, 2024
SC 13G/A Filing — Oct 17, 2024
SC 13G/A Filing — Feb 14, 2024
SC 13G/A Filing — Feb 13, 2024
Farallon Capital Partners Amends Beam Therapeutics Stake — Feb 12, 2024 Risk: low
Farallon Capital Partners, L.P. filed an amended SC 13G/A on February 12, 2024, indicating a change in their ownership of Beam Therapeutics Inc. common stock as
FMR LLC & Abigail Johnson Maintain 10.985% Stake in Beam Therapeutics — Feb 9, 2024 Risk: low
FMR LLC, a major investment firm, and its Chair and CEO, Abigail P. Johnson, have updated their ownership stake in Beam Therapeutics Inc. As of February 9, 2024
Temasek Holdings Updates Passive Stake in Beam Therapeutics — Feb 6, 2024
Temasek Holdings (Private) Ltd, a Singaporean investment company, filed an amended SC 13G/A on February 6, 2024, indicating a change in its ownership of Beam Th
ARK Investment Management Boosts Stake in Beam Therapeutics — Jan 29, 2024
ARK Investment Management LLC, led by Cathie Wood, filed an amended SC 13G/A on January 29, 2024, disclosing its ownership in Beam Therapeutics Inc. As of Decem
BlackRock Amends Beam Therapeutics Stake, Signals Continued Confidence — Jan 25, 2024
BlackRock Inc. filed an amended SC 13G/A on January 25, 2024, disclosing its ownership of Beam Therapeutics Inc. common stock as of December 31, 2023. This fili

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX